Voluntary Nationwide Recall of Brimonidine Tartrate Ophthalmic Solution, 0.15%

Article

Any patients who have received the identified lots or have any questions regarding the recall should contact their pharmacy or immediately contact a health provider in terms of medical advice.

Apotex is issuing a voluntary recall at the consumer level for six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15%, specified below. The recall is being initiated due to cracks that have developed in some of the unit caps of Brimonidine Tartrate Ophthalmic Solution bottles. The broken caps may impact sterility and the possibility of adverse events.

Brimonidine Tartrate Ophthalmic Solution is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

The six lots of Brimonidine Tartrate Ophthalmic Solution, 0.15% can be identified by national drug code numbers stated on the carton and the label of each product. One can find the lot number and expiry date located on the top flap of the carton and to the left side of the product description on the bottle label beside the barcode. The lots were distributed across the United States between April 5, 2022 and Feb. 22, 2023.

Any patients who have received the identified lots or have any questions regarding the recall should contact their pharmacy or immediately contact a health provider in terms of medical advice.

Source: FDA

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Related Content
© 2025 MJH Life Sciences

All rights reserved.